Electromed, Inc.
AMEX:ELMDMedical - Devices
Healthcare
$23.26 +1.16%
+$0.43 today
- Market cap
- $190.13M
- Beta
- 0.52
- P/E (TTM)
- 30.5
- EPS (TTM)
- $1.23
52W Low $17.73High $40.00
Volume 0.05M
Average 0.06M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
$11.39M
FY 2025 · Annual
+25.7% YoYInvesting Cash Flow
-$306,000.00
FY 2025 · Annual
Financing Cash Flow
-$11.88M
FY 2025 · Annual
Cash Flow Statement
USD
Metric | FY 2021 Jun 2021 | FY 2022 Jun 2022 | FY 2023 Jun 2023 | FY 2024 Jun 2024 | FY 2025 Jun 2025 |
|---|---|---|---|---|---|
| Net Income | 2.36M | 2.31M | 3.17M | 5.15M | 7.54M |
| Depreciation & Amortization | 610K | 628K | 613K | 841K | 1.17M |
| Deferred Income Tax | (294K) | (489K) | (43K) | (571K) | (310K) |
| Stock-Based Compensation | 1.02M | 976K | 708K | 1.69M | 3.06M |
| Change in Working Capital | (625K) | (4.11M) | (3.13M) | 1.96M | (277K) |
| Accounts Receivables | (3.58M) | (3.91M) | (3.28M) | 565K | (1.64M) |
| Inventory | 971K | (1.07M) | (1.03M) | 459K | 175K |
| Accounts Payables | 214K | 2.17M | 420K | (1.21M) | 1.65M |
| Other Working Capital | 1.77M | (1.29M) | 763K | 2.14M | (458K) |
| Other Non-Cash Items | 0 | 0 | 0 | 0 | 212K |
| Operating Cash Flow | 3.08M | (686K) | 1.32M | 9.07M | 11.39M |
| Capital Expenditures | (448K) | (1.53M) | (1.72M) | (395K) | (306K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (161K) | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (448K) | (1.53M) | (1.72M) | (395K) | (306K) |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (1.12M) | (1.45M) | (153K) | (275K) | (10M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (95K) | (77K) | (227K) | 311K | (1.88M) |
| Financing Cash Flow | (1.22M) | (1.53M) | (380K) | 36K | (11.88M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 1.41M | (3.74M) | (781K) | 8.71M | (793K) |
| Free Cash Flow | 2.63M | (2.21M) | (401K) | 8.67M | 11.09M |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income$7.5M
+ D&A$1.2M
+ Stock-Based Comp$3.1M
- Deferred Tax-$310.0K
- Working Capital-$277.0K
+ Other Non-Cash$212.0K
= Operating Cash Flow$11.4M
- Capex-$306.0K
= Free Cash Flow$11.1M
Analysis
FY2025 free cash flow is $11.1M. FCF conversion is 147.1% of net income. Operating cash flow was $11.4M, with capex of -$306.0K. The largest bridge item is Stock-Based Comp at $3.1M.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 10, 2026 | |
| 8-K | Current report | Nov 10, 2026 | |
| DEF 14A | DEF 14A filing | Sep 29, 2026 | |
| ARS | ARS filing | Sep 29, 2026 | |
| DEFA14A | DEFA14A filing | Sep 29, 2026 |
Does ELMD generate free cash flow?
Electromed, Inc. (ELMD) generated $11.09M of free cash flow in fiscal 2025.
How much operating cash flow does ELMD produce?
Operating cash flow was $11.39M, before capital expenditures of $306,000.00.
Continue the stock analysis
Jump to another research area for this company.